BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15291363)

  • 1. Retinoic acid receptor antagonist inhibits CD38 antigen expression on human hematopoietic cells in vitro.
    Prus E; Chandraratna RA; Fibach E
    Leuk Lymphoma; 2004 May; 45(5):1025-35. PubMed ID: 15291363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of tetraethylenepentamine, a synthetic copper chelating polyamine, on expression of CD34 and CD38 antigens on normal and leukemic hematopoietic cells.
    Prus E; Peled T; Fibach E
    Leuk Lymphoma; 2004 Mar; 45(3):583-9. PubMed ID: 15160922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of retinoids for the expression of CD38 on human hematopoietic progenitors in vitro.
    Muench MO; Bárcena A; Ohkubo T; Harrison MR
    Cytotherapy; 1999; 1(6):455-68. PubMed ID: 20426546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha.
    Drach J; McQueen T; Engel H; Andreeff M; Robertson KA; Collins SJ; Malavasi F; Mehta K
    Cancer Res; 1994 Apr; 54(7):1746-52. PubMed ID: 7511050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid induction of CD38 antigen expression on normal and leukemic human myeloid cells: relationship with cell differentiation.
    Prus E; Fibach E
    Leuk Lymphoma; 2003 Apr; 44(4):691-8. PubMed ID: 12769347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-trans-retinoic acid up-regulates CD38 but not c-Kit antigens on human marrow CD34+ cells without recruitment into cell cycle.
    Herault O; Domenech J; Degenne M; Bremond JL; Sensebe L; Bernard MC; Binet C; Colombat P
    Br J Haematol; 1998 Nov; 103(2):343-50. PubMed ID: 9827903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD34(+)CD38(neg) population is significantly increased in haemopoietic cell expansion cultures in serum-free compared to serum-replete conditions: dissociation of phenotype and function.
    Donaldson C; Denning-Kendall P; Bradley B; Hows J
    Bone Marrow Transplant; 2001 Feb; 27(4):365-71. PubMed ID: 11313665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38- cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells.
    Kawakami M; Kimura T; Kishimoto Y; Tatekawa T; Baba Y; Nishizaki T; Matsuzaki N; Taniguchi Y; Yoshihara S; Ikegame K; Shirakata T; Nishida S; Masuda T; Hosen N; Tsuboi A; Oji Y; Oka Y; Ogawa H; Sonoda Y; Sugiyama H; Kawase I; Soma T
    Leukemia; 2004 May; 18(5):912-21. PubMed ID: 14999295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo expansion of human UC blood primitive hematopoietic progenitors and transplantable stem cells using human primary BM stromal cells and human AB serum.
    Yamaguchi M; Hirayama F; Murahashi H; Azuma H; Sato N; Miyazaki H; Fukazawa K; Sawada K; Koike T; Kuwabara M; Ikeda H; Ikebuchi K
    Cytotherapy; 2002; 4(2):109-18. PubMed ID: 12006206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34+CD38- is a good predictive marker of cloning ability and expansion potential of CD34+ cord blood cells.
    Encabo A; Mateu E; Carbonell-Uberos F; Miñana MD
    Transfusion; 2003 Mar; 43(3):383-9. PubMed ID: 12675725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional cloning of IGFBP-3 from human microvascular endothelial cells reveals its novel role in promoting proliferation of primitive CD34+CD38- hematopoietic cells in vitro.
    Liu LQ; Sposato M; Liu HY; Vaudrain T; Shi MJ; Rider K; Stevens Z; Visser J; Deng HK; Kraus M
    Oncol Res; 2003; 13(6-10):359-71. PubMed ID: 12725526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatidylinositol 3-kinases are involved in the all-trans retinoic acid-induced upregulation of CD38 antigen on human haematopoietic cells.
    Lewandowski D; Linassier C; Iochmann S; Degenne M; Domenech J; Colombat P; Binet C; Hérault O
    Br J Haematol; 2002 Aug; 118(2):535-44. PubMed ID: 12139742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tresperimus on ex vivo expansion of CD34+CD38(-)-enriched cord blood cells.
    el Marsafy S; Dutartre P; Gluckman E
    Haematologia (Budap); 2002; 32(4):327-36. PubMed ID: 12803107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte-colony stimulating factor and stem cell factor are the crucial factors in long-term culture of human primitive hematopoietic cells supported by a murine stromal cell line.
    Nishi N; Ishikawa R; Inoue H; Nishikawa M; Kakeda M; Yoneya T; Tsumura H; Ohashi H; Yamaguchi Y; Motoki K; Sudo T; Mori KJ
    Exp Hematol; 1996 Sep; 24(11):1312-21. PubMed ID: 8862442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S; Law P; Young D; Ho AD
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of human CD34+CD38- cord blood stem cells into B cell progenitors in vitro.
    Rawlings DJ; Quan S; Hao QL; Thiemann FT; Smogorzewska M; Witte ON; Crooks GM
    Exp Hematol; 1997 Jan; 25(1):66-72. PubMed ID: 8989909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. All-trans retinoic acid (ATRA) enhances maintenance of primitive human hematopoietic progenitors and skews them towards myeloid differentiation in a stroma-noncontact culture system.
    Leung AY; Verfaillie CM
    Exp Hematol; 2005 Apr; 33(4):422-7. PubMed ID: 15781332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Karyotyping, immunophenotyping, and apoptosis analyses on human hematopoietic precursor cells derived from umbilical cord blood following long-term ex vivo expansion.
    Tian H; Huang S; Gong F; Tian L; Chen Z
    Cancer Genet Cytogenet; 2005 Feb; 157(1):33-6. PubMed ID: 15676144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells.
    Wu MH; Smith SL; Dolan ME
    Stem Cells; 2001; 19(6):492-9. PubMed ID: 11713340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.